Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 89,581 | 52,231 | 39,586 | 33,768 | 33,978 |
| Marketable Securities | N/A | 2,992 | 25,994 | 40,266 | 46,382 |
| TOTAL | $92,214 | $57,913 | $68,705 | $77,813 | $84,265 |
| Non-Current Assets | |||||
| PPE Net | 1,185 | 1,213 | 1,296 | 1,401 | 1,443 |
| Other Non-Current Assets | 8,248 | 9,008 | 8,953 | 9,253 | 9,433 |
| TOTAL | $9,433 | $10,221 | $10,249 | $10,654 | $10,876 |
| Total Assets | $101,647 | $68,134 | $78,954 | $88,467 | $95,141 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,385 | 972 | 2,434 | 2,504 | 1,852 |
| Accrued Expenses | 3,228 | 3,529 | 2,732 | 3,305 | 2,131 |
| TOTAL | $5,648 | $5,501 | $6,149 | $6,775 | $4,932 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,949 | 4,227 | 4,484 | 4,736 | 4,984 |
| TOTAL | $3,949 | $4,227 | $4,484 | $4,736 | $4,984 |
| Total Liabilities | $9,597 | $9,728 | $10,633 | $11,511 | $9,916 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,630 | 20,590 | 11,434 | 11,365 | 11,329 |
| Common Shares | 21 | 11 | 11 | 11 | 11 |
| Retained earnings | -220,992 | -211,479 | -200,384 | -190,163 | -180,303 |
| Other shareholders' equity | 0 | -1 | -31 | -165 | -336 |
| TOTAL | $92,050 | $58,406 | $68,321 | $76,956 | $85,225 |
| Total Liabilities And Equity | $101,647 | $68,134 | $78,954 | $88,467 | $95,141 |